04:00 PM EDT, 09/16/2025 (MT Newswires) -- Health care stocks were mixed late Tuesday afternoon, with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) fractionally lower.

The iShares Biotechnology ETF (IBB) increased 0.2%.

In corporate news, Novo Nordisk ( NVO ) intends to file a request with the US Food and Drug Administration for approval of a higher dose version of its weight-loss drug Wegovy, Bloomberg reported. Novo shares rose 2.7%.

Eli Lilly ( LLY ) shares rose 2.1% after the firm said it plans to build a $5 billion plant in Goochland County, Virginia, to make active pharmaceutical ingredients and drug products. Separately, Eli Lilly's ( LLY ) investigational oral weight-loss drug orforglipron could be approved by the FDA before the end of the year under a new one-to-two-month priority review process, Reuters reported.

The US FDA issued a warning letter to Hims & Hers Health ( HIMS ) on Sept. 9, stating that claims on its website about its compounded semaglutide product are false or misleading. The letter was made available to the public on Tuesday. Hims shares dropped 5.8%.

Oscar Health ( OSCR ) shares fell over 4% after the company said it priced an upsized offering of $355 million of 2.25% convertible senior subordinated unsecured notes due 2030.